New Delhi: Eleven countries in the world have already recognised Indian pharmacopoeia as their standard said Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI). The DGCI said “India is supplying drugs, vaccines and medical devices to more than 200 countries world over; 11 countries in the world have already recognised Indian pharmacopoeia as their standard.” He further added “Now we are approving on an average, 100 global clinical trials every year for the last couple of years, and that shows the face of international research organizations and functional companies on the regulatory system which we are developing and developed till now.”
“On our part, India, Indian NRA, is reviewing and has approved the latest technology-based products like car T cell therapy, mRNA vaccine, software as medical devices, which shows that we are going through continuous upgradation of skills and capacity within our regulatory system. Recently, we notified six countries from where products of five designated categories are applied for approval in India,” Raghuvanshi further said. In October, the Ministry of Health and Family Welfare said that the Central Drugs Standard Control Organisation (CDSCO), along with the National Regulatory Authority of India (NRA) and affiliated institutions, has been found to meet international standards for vaccine regulations set by the World Health Organisation (WHO). The WHO-led expert’s team approved India’s vaccine regulatory system after an in-depth scientific review, conducted between September 16 and 20, as per a statement by the Ministry of Health and Family Welfare.